中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
13期
136-138,139
,共4页
人附睾分泌蛋白4%肿瘤标记%子宫内膜癌%诊断%预后
人附睪分泌蛋白4%腫瘤標記%子宮內膜癌%診斷%預後
인부고분비단백4%종류표기%자궁내막암%진단%예후
Human epididymis protein 4%Tumor marker%Endometrial Cancer%Diagnosis%Prognosis
人附睾蛋白4（HE4）是近年来发现的新型的血清学标志物，目前在卵巢上皮性癌已经得到广泛应用。近来研究发现，HE4在子宫内膜癌组织中高表达，国内外学者及机构已经就其高敏感性和特异性作为子宫内膜癌的肿瘤标志物开展研究。现就HE4在子宫内膜癌中的研究进展、临床意义等做一综述。
人附睪蛋白4（HE4）是近年來髮現的新型的血清學標誌物，目前在卵巢上皮性癌已經得到廣汎應用。近來研究髮現，HE4在子宮內膜癌組織中高錶達，國內外學者及機構已經就其高敏感性和特異性作為子宮內膜癌的腫瘤標誌物開展研究。現就HE4在子宮內膜癌中的研究進展、臨床意義等做一綜述。
인부고단백4（HE4）시근년래발현적신형적혈청학표지물，목전재란소상피성암이경득도엄범응용。근래연구발현，HE4재자궁내막암조직중고표체，국내외학자급궤구이경취기고민감성화특이성작위자궁내막암적종류표지물개전연구。현취HE4재자궁내막암중적연구진전、림상의의등주일종술。
Human epididymis protein 4 (HE4) is a new tumor marker which is widely used in diagnosing ovarian cancer. Recent studies have demonstrated that HE4 was highly expressed in endometrial cancer. During the last years, an increasing interest by scholars and organizations had been growing on HE4 as endometrial cancer tumor markers that demonstrated to be a useful clinical marker with high sensitivity and specificity. This review will briefly summarize the progress and the clinical significance of HE4 in endometrial cancer.
